Table II.
Expression level of FGF5 | ||||
---|---|---|---|---|
|
||||
Clinicopathological characteristics | Number of patients | Low (<median) | High (≥ median) | P-value |
Number | 43 | 21 | 22 | |
Age, years | 0.429 | |||
<60 | 18 | 8 | 10 | |
≥60 | 25 | 13 | 12 | |
Sex | 0.227 | |||
Female | 19 | 11 | 8 | |
Male | 24 | 10 | 14 | |
TNM stage | 0.04 | |||
I/II | 20 | 14 | 6 | |
III/IV | 23 | 7 | 16 | |
Pathological type | 0.745 | |||
Squamous | 22 | 10 | 12 | |
Adenocarcinoma | 14 | 8 | 6 | |
Large cell lung cancer | 7 | 3 | 4 | |
Smoking status | 0.760 | |||
Non-smoker | 17 | 10 | 7 | |
Smoker | 26 | 11 | 15 | |
Lymphatic Metastasis | 0.012 | |||
No | 16 | 12 | 4 | |
Yes | 27 | 9 | 16 |
FGF5, fibroblast growth factor 5.